Literature DB >> 3098801

In vitro stimulation of plasminogen activator release from vein walls by adrenaline.

A Kjaeldgaard, M Kjaeldgaard.   

Abstract

The effect of adrenaline on plasminogen activator release was studied in vitro in human vein biopsy specimens, in which the fibrinolytic activity was determined according to the fibrin slide technique. The tissue slides were covered with a thin fibrin film containing 10(-9) and 10(-7) M adrenaline and exposed for 30 to 60 minutes. In both concentrations highly significant (p less than 0.001) enhancement of fibrinolytic activity was shown, and the enhancement of fibrinolysis was most pronounced during the first 30 minutes of exposure. Stimulation of fibrinolysis was maximal after exposure to the physiological concentration of 10(-9) M, while no further increase was seen using the pharmacological concentration. These results show that adrenaline has a stimulant effect on tissue fibrinolysis in vitro, and this effect may account for the direct stimulation of fibrinolysis by adrenaline in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098801      PMCID: PMC1140771          DOI: 10.1136/jcp.39.11.1241

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Studies on the release of plasminogen activator.

Authors:  F Markwardt; H P Klöcking
Journal:  Thromb Res       Date:  1976-02       Impact factor: 3.944

2.  Histochemistry and assay of plasminogen activator.

Authors:  M Pandolfi
Journal:  Rev Eur Etud Clin Biol       Date:  1972-03

3.  The effect propranolol, alprenolol and practolol on the vibrinolytic and factor VIII responses to adrenaline and salbutamol in man.

Authors:  A M Gader; J Da Costa; J D Cash
Journal:  Thromb Res       Date:  1974-01       Impact factor: 3.944

4.  Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.

Authors:  S Isacson; I M Nilsson
Journal:  Acta Chir Scand       Date:  1972

5.  Fibrinolytic activity of human veins in arms and legs.

Authors:  M Pandolfi; B Robertson; S Isacson; I M Nilsson
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

6.  Effect of prednisolone on the coagulation and fibrinolytic systems.

Authors:  S Isacson
Journal:  Scand J Haematol       Date:  1970

7.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall.

Authors:  D C Rijken; G Wijngaards; J Welbergen
Journal:  Thromb Res       Date:  1980-06-15       Impact factor: 3.944

8.  Studies of the blood plasminogen activator induced by 1-desamino-8-D-arginine vasopressin with observations in von Willebrand's disease.

Authors:  L Holmberg; I M Nilsson; P Wallén; B Astedt
Journal:  Proc Soc Exp Biol Med       Date:  1982-06

9.  Release of plasminogen activator by acetylcholine from the isolated perfused pig ear.

Authors:  H P Klöcking
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

10.  delta 4-ethylestrenol in recurrent deep venous thrombosis.

Authors:  B Nilsson; I M Nilsson; U Hedner
Journal:  Acta Med Scand       Date:  1981
View more
  3 in total

Review 1.  Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?

Authors:  J D Rutherford
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

2.  Potential Antithrombotic and Fibrinolytic Properties of the Angiotensin Converting Enzyme Inhibitors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

3.  Epinephrine exerts anticoagulant effects during human endotoxemia.

Authors:  T van der Poll; M Levi; M Dentener; P M Jansen; S M Coyle; C C Braxton; W A Buurman; C E Hack; J W ten Cate; S F Lowry
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.